ZA866200B - Pharmaceutical compositions consisting of acylated phospholipids - Google Patents

Pharmaceutical compositions consisting of acylated phospholipids

Info

Publication number
ZA866200B
ZA866200B ZA866200A ZA866200A ZA866200B ZA 866200 B ZA866200 B ZA 866200B ZA 866200 A ZA866200 A ZA 866200A ZA 866200 A ZA866200 A ZA 866200A ZA 866200 B ZA866200 B ZA 866200B
Authority
ZA
South Africa
Prior art keywords
appropriate
pharmaceutically acceptable
phospholipid
alkylene
atoms
Prior art date
Application number
ZA866200A
Other languages
English (en)
Inventor
Alan J Schroit
Raijiv Nayar
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of ZA866200B publication Critical patent/ZA866200B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA866200A 1985-08-19 1986-08-18 Pharmaceutical compositions consisting of acylated phospholipids ZA866200B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76662585A 1985-08-19 1985-08-19

Publications (1)

Publication Number Publication Date
ZA866200B true ZA866200B (en) 1987-03-25

Family

ID=25077017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA866200A ZA866200B (en) 1985-08-19 1986-08-18 Pharmaceutical compositions consisting of acylated phospholipids

Country Status (18)

Country Link
EP (1) EP0213523B1 (no)
JP (1) JPS6296431A (no)
KR (1) KR870001838A (no)
AT (1) ATE59002T1 (no)
AU (1) AU591162B2 (no)
CA (1) CA1273575A (no)
DD (1) DD248736A5 (no)
DE (1) DE3676133D1 (no)
DK (1) DK165314C (no)
ES (1) ES2001099A6 (no)
FI (1) FI863311A (no)
GR (1) GR862144B (no)
HU (1) HU206045B (no)
NO (1) NO171886C (no)
NZ (1) NZ217239A (no)
PH (1) PH26160A (no)
PT (1) PT83204B (no)
ZA (1) ZA866200B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256989A1 (en) * 1986-08-18 1988-02-24 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
AU7496991A (en) * 1990-03-20 1991-10-21 Otsuka Pharmaceutical Co., Ltd. Liposome preparation
DK0699068T3 (da) * 1993-05-21 2002-03-11 Liposome Co Inc Reduktion af liposominducerede fysiologiske bivirkninger
DK0785773T3 (da) * 1994-10-14 2001-01-29 Liposome Co Inc Etherlipidliposomer og deres terapeutiske anvendelse
US6589503B1 (en) 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7306784B2 (en) 1998-06-20 2007-12-11 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
WO2006026184A2 (en) 2004-08-20 2006-03-09 Washington University Blood brain barrier permeation peptides
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20200197547A1 (en) 2017-08-30 2020-06-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218027A1 (de) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidloesungen

Also Published As

Publication number Publication date
PH26160A (en) 1992-03-18
NZ217239A (en) 1989-09-27
ES2001099A6 (es) 1988-04-16
HU206045B (en) 1992-08-28
DE3676133D1 (de) 1991-01-24
CA1273575A (en) 1990-09-04
PT83204B (pt) 1989-03-30
FI863311A (fi) 1987-02-20
EP0213523A2 (de) 1987-03-11
JPS6296431A (ja) 1987-05-02
EP0213523B1 (de) 1990-12-12
FI863311A0 (fi) 1986-08-15
AU6155686A (en) 1987-02-26
NO863315D0 (no) 1986-08-18
DD248736A5 (de) 1987-08-19
HUT41634A (en) 1987-05-28
DK165314B (da) 1992-11-09
NO171886B (no) 1993-02-08
NO863315L (no) 1987-02-20
DK392786D0 (da) 1986-08-18
EP0213523A3 (en) 1987-10-14
PT83204A (en) 1986-09-01
AU591162B2 (en) 1989-11-30
DK165314C (da) 1993-03-29
KR870001838A (ko) 1987-03-28
GR862144B (en) 1986-12-23
DK392786A (da) 1987-02-20
ATE59002T1 (de) 1990-12-15
NO171886C (no) 1993-05-19

Similar Documents

Publication Publication Date Title
AU591162B2 (en) Pharmaceutical compositions consisting of acylated phospholipids
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
NZ223262A (en) 11-arylestra-4,9-dien-3-ones, derivatives and pharmaceutical compositions
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
ES514240A0 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
EP0237051A3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
FI904850A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi
HUT35957A (en) Process for producing phosholipide compositions and pharmaceutical compositions containing them as active agents
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI834702A (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning.
IL87254A0 (en) Stable oxapenem-3-carboxylic acids,their preparation and pharmaceutical compositions containing them
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
ES8207538A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
ES2087421T3 (es) Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
PT86422A (fr) Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant